HLS Therapeutics (TSE:HLS) Has Affirmed Its Dividend Of $0.05
Nov 30
Canadian (TSX) Healthcare Sector Analysis
UpdatedDec 01, 2022
DataAggregated Company Financials
Companies247
- 7D0.4%
- 3M-7.3%
- 1Y-43.5%
- YTD-42.3%
Over the last 7 days, the Healthcare industry has remained flat, although notably BELLUS Health gained 9.7%. Unfortunately though, the industry is down 43% over the past 12 months. Earnings are forecast to grow by 59% annually.
Sector Valuation and Performance
Has the Canadian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 01 Dec 2022 | CA$44.9b | CA$21.9b | -CA$11,730,228,646.00 | 19.9x | -3.8x | 2x |
| Sat, 29 Oct 2022 | CA$41.9b | CA$21.3b | -CA$10,838,556,856.00 | 22x | -3.9x | 2x |
| Mon, 26 Sep 2022 | CA$40.4b | CA$21.3b | -CA$10,850,023,985.00 | 22.6x | -3.7x | 1.9x |
| Wed, 24 Aug 2022 | CA$46.2b | CA$20.8b | -CA$10,393,010,999.00 | 23.8x | -4.4x | 2.2x |
| Fri, 22 Jul 2022 | CA$46.5b | CA$19.7b | -CA$7,319,052,088.00 | 20.5x | -6.3x | 2.4x |
| Sun, 19 Jun 2022 | CA$43.5b | CA$19.9b | -CA$7,482,319,759.00 | 17.6x | -5.8x | 2.2x |
| Tue, 17 May 2022 | CA$50.1b | CA$19.6b | -CA$7,222,192,948.00 | 19.4x | -6.9x | 2.6x |
| Thu, 14 Apr 2022 | CA$61.2b | CA$18.6b | -CA$6,264,578,592.00 | 20.7x | -9.8x | 3.3x |
| Sat, 12 Mar 2022 | CA$58.0b | CA$17.6b | -CA$6,041,136,009.00 | 19.1x | -9.6x | 3.3x |
| Mon, 07 Feb 2022 | CA$68.2b | CA$17.7b | -CA$6,747,116,939.00 | 20.1x | -10.1x | 3.9x |
| Wed, 05 Jan 2022 | CA$74.0b | CA$17.5b | -CA$6,764,416,374.00 | 20.1x | -10.9x | 4.2x |
| Fri, 03 Dec 2021 | CA$78.7b | CA$17.5b | -CA$6,604,721,825.00 | 18.1x | -11.9x | 4.5x |
| Sun, 31 Oct 2021 | CA$84.3b | CA$16.5b | -CA$6,594,261,337.00 | 16.9x | -12.8x | 5.1x |
| Tue, 28 Sep 2021 | CA$95.8b | CA$16.7b | -CA$8,427,344,597.00 | 21.3x | -11.4x | 5.7x |
| Thu, 26 Aug 2021 | CA$92.1b | CA$16.5b | -CA$8,242,368,311.80 | 22.4x | -11.2x | 5.6x |
| Fri, 02 Jul 2021 | CA$105.8b | CA$16.5b | -CA$8,237,704,690.80 | 24.2x | -12.8x | 6.4x |
| Mon, 05 Apr 2021 | CA$108.5b | CA$13.8b | -CA$9,019,397,133.43 | 27.5x | -12x | 7.8x |
| Thu, 07 Jan 2021 | CA$73.5b | CA$11.7b | -CA$9,695,320,740.67 | 30.7x | -7.6x | 6.3x |
| Wed, 30 Sep 2020 | CA$50.2b | CA$11.2b | -CA$10,819,866,331.35 | 28x | -4.6x | 4.5x |
| Sat, 04 Jul 2020 | CA$45.9b | CA$10.3b | -CA$9,438,609,745.00 | 32.7x | -4.9x | 4.5x |
| Tue, 07 Apr 2020 | CA$36.7b | CA$10.0b | -CA$6,973,288,746.59 | 16.6x | -5.3x | 3.7x |
| Fri, 10 Jan 2020 | CA$50.6b | CA$8.8b | -CA$5,030,853,647.32 | 25x | -10.1x | 5.7x |
Price to Earnings Ratio
-14.2x
Current Industry PE
- Investors are pessimistic on the Canadian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 4.8x is higher than the industry's current PS ratio of 2.0x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 41% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the Canadian Healthcare sector?
| CA Market | 0.70% | |
| Healthcare | 0.36% | |
| Biotech | 5.33% | |
| Medical Equipment | 2.74% | |
| Healthcare Services | 1.77% | |
| Healthtech | -0.38% | |
| Pharma | -0.63% | |
| Life Sciences | -5.51% | |
Industry PE
Forecasted Growth
- Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 63% over the next 5 years.
- This is better than its past earnings growth rate of 15% per year.
- In contrast, the Biotech industry is expected to see its earnings grow by 8.3% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BLU BELLUS Health | CA$13.36 | 9.7% +CA$148.4m | 81.5% | PS82249.2x | |
| DNTL dentalcorp Holdings | CA$9.07 | 7.8% +CA$122.5m | -44.4% | PS1.4x | |
| WEED Canopy Growth | CA$4.86 | 4.1% +CA$92.3m | -61.9% | PS4.9x | |
| CURA Curaleaf Holdings | CA$8.98 | 0.6% +CA$35.9m | -21.6% | PS3.6x | |
| TRUL Trulieve Cannabis | CA$17.56 | 1.0% +CA$33.5m | -47.7% | PS1.9x |
